Withdrawal of active treatment after intracerebral haemorrhage in the INTERACT2 study.

ABSTRACT:

Background

in the second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT2), a minority of patients received withdrawal of active treatment (WAT). We wished to determine the characteristics of these patients, and the relation of this decision-making to subsequent management and final outcome.

Methods

the INTERACT2 cohort of acute intracerebral haemorrhage (ICH) patients had a decision of WAT within 7 days after hospital admission recorded. Multivariable logistic regression was used to identify the determinants of WAT and poor outcome at 90 days, defined by modified Rankin scale (mRS) scores 3-6.

Results

of 2,779 participants with available data, WAT occurred in 121 (4%) and this was significantly associated with increasing age, greater

SUBMITTER: Munoz Venturelli P 

PROVIDER: S-EPMC6402307 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature